RDH16 | Retinol dehydrogenase 16 (all-trans) | Predicted membrane proteins
| | | | | Tissue enriched |
APOF | Apolipoprotein F | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
F13B | Coagulation factor XIII, B polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HRG | Histidine-rich glycoprotein | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
PLGLB2 | Plasminogen-like B2 | Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C8 | Cytochrome P450, family 2, subfamily C, polypeptide 8 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A9 | Solute carrier family 22 (organic anion transporter), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CYP2A13 | Cytochrome P450, family 2, subfamily A, polypeptide 13 | Enzymes
| | | | | Tissue enriched |
C8A | Complement component 8, alpha polypeptide | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
UGT2B10 | UDP glucuronosyltransferase 2 family, polypeptide B10 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CA5A | Carbonic anhydrase VA, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
INHBC | Inhibin, beta C | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FGF21 | Fibroblast growth factor 21 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted membrane proteins Transcription factors
| | | | | Group enriched |
F7 | Coagulation factor VII (serum prothrombin conversion accelerator) | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | | | | | | Group enriched |
CYP2E1 | Cytochrome P450, family 2, subfamily E, polypeptide 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SLC22A7 | Solute carrier family 22 (organic anion transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
HPR | Haptoglobin-related protein | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes
| | | | | Group enriched |
CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
C8B | Complement component 8, beta polypeptide | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFHR1 | Complement factor H-related 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PRAMEF10 | PRAME family member 10 | | | | | | Tissue enriched |
CCL16 | Chemokine (C-C motif) ligand 16 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TRPM8 | Transient receptor potential cation channel, subfamily M, member 8 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
ORM1 | Orosomucoid 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC38A4 | Solute carrier family 38, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AL158147.2 | HCG2011465; Uncharacterized protein | | | | | | Group enriched |
INS-IGF2 | INS-IGF2 readthrough | Predicted secreted proteins
| | | | | Tissue enriched |
CYP7A1 | Cytochrome P450, family 7, subfamily A, polypeptide 1 | Enzymes
| | | | | Tissue enriched |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Tissue enriched |
PLGLB1 | Plasminogen-like B1 | Predicted secreted proteins
| | | | | Tissue enriched |
AL138847.1 | CDNA FLJ26506 fis, clone KDN07105; Uncharacterized protein | Predicted secreted proteins
| | | | | Group enriched |
CPN1 | Carboxypeptidase N, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CYP2A7 | Cytochrome P450, family 2, subfamily A, polypeptide 7 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLKB1 | Kallikrein B, plasma (Fletcher factor) 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
LPA | Lipoprotein, Lp(a) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |